Tuesday, November 15, 2016
- 9:00AM-11:00AM
-
Abstract Number: 2732
Meaningful Involvement of Patients in the Development of a Core Outcome Set for Psoriatic Arthritis
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2429
Mechanisms for the Development of Lung Fibrosis in Sting-Associated Vasculopathy with Onset in Infancy (SAVI)
Pediatric Rheumatology – Pathogenesis and Genetics - Poster- 9:00AM-11:00AM
-
Abstract Number: 2927
Mechanisms Regulating the Loss of Tregs in CD11c-Flip-KO Mice That Contribute to the Spontaneous Development of Inflammatory Arthritis
T Cell Biology and Targets in Autoimmune Disease - Poster Session II- 9:00AM-11:00AM
-
Abstract Number: 2208
Mediators of the Relationship Between Pain and Disability in the Distal Upper Limb
Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes - Poster II: Clinical Focus- 9:00AM-11:00AM
-
Abstract Number: 2393
Medication Use in the Juvenile Systemic Sclerosis Inception Cohort. ARE There Differences in the Diffuse and Limited Subset Patients?
Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster III: Systemic JIA, Autoinflammatory Syndromes, Scleroderma, Vasculitis, Miscellaneous- 9:00AM-11:00AM
-
Abstract Number: 2406
Mental Health Care for Adolescents with Rheumatologic Conditions: Perspectives from Pediatric Behavioral Health Providers in North America
Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster III: Systemic JIA, Autoinflammatory Syndromes, Scleroderma, Vasculitis, Miscellaneous- 9:00AM-11:00AM
-
Abstract Number: 2784
Mesenchymal Stem Cells Ameliorate Lupus By Promoting T Cell Apoptosis Via Bcl-2/Bim Independent Pathway in MRL/Lpr Mice
Systemic Lupus Erythematosus – Animal Models - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2168
Metabolic Syndrome, All Cause Mortality and Atherosclerotic Cardiovascular Disease in Rheumatic Diseases
Epidemiology and Public Health - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2532
Methotrexate Adherence in an Online Network of Patients with Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events- 9:00AM-11:00AM
-
Abstract Number: 2261
Methotrexate Inhibits Intracellular Redox Signaling Induced By the Reactive Oxygen Species; Malondialdehyde and Acetaldehyde
Innate Immunity and Rheumatic Disease - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2836
Microparticles of Endothelial Origin in Women with Systemic LUPUS Erythematosus UNDER Treatment
Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster III: Biomarkers and Nephritis- 9:00AM-11:00AM
-
Abstract Number: 2414
Microrna Associated with Active Systemic Juvenile Idiopathic Arthritis Regulate CD163 Expression in Polarized Macrophages through Two Distinct Mechanisms
Pediatric Rheumatology – Pathogenesis and Genetics - Poster- 9:00AM-11:00AM
-
Abstract Number: 2099
Micrornas As Potential Modulators of Atherothrombosis in Antiphospholipid Syndrome
Antiphospholipid Syndrome - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2897
Microvascular Function in Systemic Sclerosis Patients with End-Stage Vascular Manifestations of the Disease